ASX News Health Care Race identifies 39 new molecules with potential to inhibit cancer-associated protein Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University… Caroline Smith2 mins21 November 2024 11:39 (AEDT)
ASX News Health Care Radiopharm extends radioimmunotherapy trial to 5 more cancer types Radiopharm Theranostics Ltd has received approval to extend its Phase 1 trial of Lu-RAD204 to five… Caroline Smith2 mins19 November 2024 14:55 (AEDT)
ASX News Health Care Actinogen receives $9M R&D tax rebate to fund Alzheimer’s trial Actinogen Medical Ltd has received a $9M R&D rebate from the Australian Taxation Office which will… Caroline Smith1 min12 November 2024 13:41 (AEDT)
ASX News Health Care Imugene kicks off Australian trial for blood cancer treatment Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test… Caroline Smith2 mins08 November 2024 13:33 (AEDT)
ASX News Health Care Recce reaches key dosing milestone in testing of skin infection gel Recce Pharmaceuticals Ltd has successfully dosed 20 out of 30 participants in its Phase II trial… Caroline Smith2 mins05 November 2024 12:59 (AEDT)
ASX News Health Care Dimerix links up with US NEPTUNE network to boost recruitment for FSGS study Dimerix Ltd is set to partner with a key research network at the University of Michigan… Caroline Smith2 mins01 November 2024 16:19 (AEDT)
ASX News Health Care Emyria, UWA seek commercialisation of compounds to treat PTSD and Parkinson’s Emyria and the University of Western Australia have formed a partnership to secure global rights to… Caroline Smith2 mins31 October 2024 11:18 (AEDT)
ASX News Health Care FDA awards Argenica two key designations for drug candidate targeting infant brain injury Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for… Caroline Smith2 mins30 October 2024 14:45 (AEDT)
ASX News Health Care Tryptamine to plug $6M placement funding into acceleration of IV-infused psilocybin treatment trials Tryptamine Therapeutics Ltd has confirmed interest from investors in a Placement worth $6M to boost clinical… Caroline Smith2 mins30 October 2024 10:59 (AEDT)
ASX News Health Care Arovella snaffles R&D rebate worth $3M for cancer cell therapy research Arovella Therapeutics Ltd has received $3M from the Federal government for its research, and is anticipating… Caroline Smith2 mins25 October 2024 13:55 (AEDT)